We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$413M
AUM Growth
-$90.6M
Cap. Flow
-$16.2M
Cap. Flow %
-3.92%
Top 10 Hldgs %
90.55%
Holding
26
New
2
Increased
7
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$2.82M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$2.6M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.75M
4
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.32M
5
EPZM
Epizyme, Inc
EPZM
+$565K

Top Sells

Rank Stock Value
1
MZOR
Mazor Robotics Ltd.
MZOR
+$65.6M
2
AXDX
Accelerate Diagnostics
AXDX
+$4.46M
3
AMRN
Amarin Corp
AMRN
+$4.18M
4
TSRO
TESARO, Inc.
TSRO
+$2.99M
5
QDEL icon
QuidelOrtho
QDEL
+$2.43M

Sector Composition

Rank Sector Weight
1 Healthcare 95.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
26
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-65,000
Closed -$211K
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Oracle Investment Management held 26 positions worth $413M, down 18% from $503M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Oracle Investment Management withdrew a net $16.2M in Q1 2018, closing 5 positions and reducing 6 holdings. Its most notable exit was Precigen, an estimated $2.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 86% a quarter earlier.

Against the trend, Oracle Investment Management opened a new position in Chinook Therapeutics, Inc. Common Stock worth $2.22M.

  • Oracle Investment Management's largest Q1 2018 buy was Chinook Therapeutics, Inc. Common Stock: 47,696 shares worth $2.22M.
  • Oracle Investment Management added most to Pacific Biosciences in Q1 2018, an estimated $2.82M increase.
  • Oracle Investment Management's biggest Q1 2018 reduction was Mazor Robotics Ltd., cutting an estimated $65.6M.
  • Oracle Investment Management fully exited Precigen in Q1 2018, selling an estimated $2.25M.
  • Oracle Investment Management's ten largest holdings make up 91% of its $413M portfolio in Q1 2018.
  • Oracle Investment Management opened 2 new positions and closed 5 in Q1 2018.
  • Oracle Investment Management's portfolio value fell 18% quarter-over-quarter to $413M.

Based on Oracle Investment Management's 13F filing for Q1 2018, filed 15 May 2018.